Session Information
Date: Sunday, November 12, 2023
Title: (0673–0690) Vasculitis – ANCA-Associated Poster I: Treatment Outcomes
Session Type: Poster Session A
Session Time: 9:00AM-11:00AM
Background/Purpose: To assess how and to what extent race, ethnicity, sex, gender and socioeconomic status of participants are reported in ANCA-associated vasculitis (AAV) randomized controlled trials (RCTs), and to estimate the representativeness of different ethnic/racial groups in AAV-RCTs.
Methods: We searched all published AAV-RCTs indexed in PubMed and Embase since 2000. We retrieved information on main features of RCTs published from 2000 to 2022 and recorded for each study whether participant race/ethnicity, socioeconomic status (SES) and sex/gender were reported; how ethnicity/race was defined and assigned; the number of patients included for each racial/ethnic group. Descriptive statistics was used to summarize the main study results.
Results: We included 45 studies enrolling a total of 5053 patients (42% recruiting in more than one country), mostly published between 2011 – 2022 (62%), including patients with mainly granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA) (68%), and mainly investigating pharmacologic interventions (98%). Information on race/ethnicity was available in 9 (20%) studies, 7 of which published ≥ 2011, including a total of 1445 (28%) patients. Figure 1 (left panel) shows the number of studies reporting race/ethnicity over time. Sex and/or gender of participants was reported in all but one study, but in 33 (73%) studies the authors clearly specified whether they reported the sex or the gender. In univariate analysis, we found a better reporting of race/ethnicity for larger studies including patients from different continents, funded by industry, and being published in higher impact factor journals. In studies where race/ethnicity was reported, White patients were the most represented (90%), followed by Asian (3%) and African American (2%). Figure 1 (right panel)presents temporal trends in the proportion of included participants across racial/ethnic groups in the overall sample of studies. Studies never reported the reasons for collecting race/ethnicity or subgroup analyses focusing on race/ethnicity. Only one study provided the definitions used to identify different patient’s origin. Only one paper reported patient SES.
Conclusion: Reporting of race/ethnicity and socioeconomic status deserves to be improved in AAV-RCTs. The non-White patients are underrepresented in AAV-RCTs reporting race/ethnicity of participants.
To cite this abstract in AMA style:
Iudici M, Rueda J, Puéchal X. Reporting of Race, Ethnicity, Sex, Gender, Socioeconomic Status and Representativeness of Race and Ethnicity in ANCA-associated Vasculitis Randomized Trials [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/reporting-of-race-ethnicity-sex-gender-socioeconomic-status-and-representativeness-of-race-and-ethnicity-in-anca-associated-vasculitis-randomized-trials/. Accessed .« Back to ACR Convergence 2023
ACR Meeting Abstracts - https://acrabstracts.org/abstract/reporting-of-race-ethnicity-sex-gender-socioeconomic-status-and-representativeness-of-race-and-ethnicity-in-anca-associated-vasculitis-randomized-trials/